This phenomenon may be attributed to regenerative mechanisms, and this period of heightened permeability is linked with clinical recovery[53]
These are averages from separate trials, not head-to-head results, and individual outcomes vary widely
Tracking also matters because peptides are not standardized consumer products
Document doses to ensure consistency
Explore Drug Addiction Treatment Centers Promising Data on GLP-1s for Addiction A 2024 review identified two randomized control trials that showed a significant effect of GLP-1RA on decreasing SUD. The details: One study pertained to alcohol, the other to nicotine In the alcohol study, participants drank 29% less compared to their baseline intake (Probst et al., 2023) dulaglutide once a week for 12 weeks A third study only showed SUD results (alcohol) for patients who were also obese (Klausen et al., 2022) In this study, one GLP-1 (Exenatide) decreased total intake and the number of heavy drinking days by almost 24% once a week for 26 weeks The 2024 review concludes that GLP-1s have a a potential role in SUD
The concern is that the word can make an imprecise strategy sound advanced
